Tag: ProSomnus Sleep Technologies
ProSomnus: ‘We are enabling smart sleep medicine’
April 14, 2026HME News Staff
SAN FRANCISCO – ProSomnus Sleep Technologies has announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The company says the RPMO2 OSA Device is the first theranostic device for sleep medicine, incorporating both precision oral appliance therapy and multi-night physiologic monitoring in one device. With this new clearance, it says the device is positioned as...
ProSomnus receives $38M investment to grow in alternative sleep market
February 18, 2026HME News Staff
SAN FRANCISCO – ProSomnus has raised $38 million through a strategic investment from Catalio Capital Management to accelerate the expansion of its sleep health platform, according to a report from MassDevice.com.
ProSomnus develops non-CPAP obstructive sleep apnea (OSA) therapy offerings. With the investment, it plans to advance the development of next-generation remote patient monitoring and proprietary sleep diagnostic devices. It hopes to...
ProSomnus takes to social media
January 29, 2020HME News Staff
SAN FRANCISCO - ProSomnus Sleep Technologies has launched #ShareYourStory, a social media campaign designed to raise awareness that prescription intraoral devices are a comfortable, effective and recommended alternative to CPAP. “Few are aware that CPAP is no longer the only treatment option for people suffering from sleep breathing issues, such as OSA,” stated ProSomnus, which manufacturers such devices, in a press release. “Covered by most medical insurances and Medicare, the...